Modulo Bio
Latest round
- Seed
Last raised
- Jun 2021
Total raised
- $3.9M
Investors
- 7
About Modulo Bio
Founded in 2021 and based in California, US, Modulo Bio, Inc. operates as a biotechnology company that researches and develops drugs focused on the neuroimmune system. In March 2025, Modulo Bio, Inc. The Modulo Neuroimmune Platform, developed by the company, combines software, automation, and artificial intelligence with stem cell biology and neuroscience to pioneer new treatments for patients suffering from debilitating neurodegenerative diseases. The company creates therapeutic drugs that reprogram the neuroimmune system in order to slow or reverse disease progression.
Who invested in Modulo Bio
7 investors across 1 round
See all investors in Modulo Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 8, 2021
Amount
$3.9M
Investors
Questions about Modulo Bio
Who invested in Modulo Bio?
Modulo Bio has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Modulo Bio raised?
Modulo Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Modulo Bio last raise money?
Modulo Bio's most recent round on record is a Seed, in Jun 2021.
What does Modulo Bio do?
Founded in 2021 and based in California, US, Modulo Bio, Inc.
Where is Modulo Bio headquartered?
Modulo Bio is headquartered in San Diego, US.
Which VCs invest in companies like Modulo Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Modulo Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Modulo Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.